Wordt geladen...
Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease?
Bewaard in:
| Gepubliceerd in: | Diabetes Ther |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer Healthcare
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4374076/ https://ncbi.nlm.nih.gov/pubmed/25783754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-015-0104-4 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|